Who we are
Synotek specializes in building interpretable Digital Twins for the pharma and biotech sectors. Our focus on deep machine learning and active learning, combined with extensive pharma regulatory knowledge, enables us to deliver trusted solutions that enhance operational efficiency.
Our Mission
At Synotek, our mission is to empower pharma and biotech manufacturers with data-driven insights that mitigate risks and enhance process quality, ensuring better outcomes in manufacturing operations.
Innovation
Beyond predictive AI: learn the process itself.
Synotek goes beyond conventional predictive AI with a data-driven generative framework that captures how process conditions, operating regimes and performance interact. By assimilating both data and process knowledge, it builds a richer representation of the process that can be used to understand, predict and explore its behaviour.
Impact
Recommendations shaped by both performance and process reality.
By combining predictive intelligence, explainability and learned process context, our platform generates recommendations tailored to each operation. Proposed changes are considered through their expected performance, operating trade-offs and the strength of their support within known process behaviour, turning AI insight into decisions that are both valuable and relevant to the way the process actually operates.
Commitment
A trustworthy AI layer for regulated operations.
Integrating regulatory rules directly into AI decision pipelines ensures recommendations optimize processes strictly within legal boundaries while providing a transparent, expert-auditable foundation for operational transformation. Our support-aware approach helps distinguish recommendations grounded in known process behaviour from those relying on less familiar conditions, while process-specific knowledge, constraints and terminology keep every recommendation connected to its operational context. The result is a more transparent and defensible foundation for using AI where confidence and accountability matter.
Meet our team of experts
Our team at Synotek comprises industry-leading specialists with extensive backgrounds in machine learning, pharma regulations, and data analytics, all focused on driving our clients' success.
CEO & Co-founder
Auguste Van Lerberghe
Chief Data Officer at ballas invest, digital product & AI growth advisor, and former traffic manager, leveraging data engineering, performance marketing, and international experience to scale startups.
CTO & Co-founder
Clément Mailhé
Doctor in Engineering & AI-driven R&D specialist, focusing on advanced simulation, materials science, and machine learning models for high-impact industrial applications.
Co-founder, investor & board member
Laurent Van Lerberghe
International digital health investor, founder and managing partner of KELES, European digital health growth fund and founder & CEO of ballas invest digital health business angel, following 25 years global pharma C-suite experience
Co-founder, investor & board member
Dominique Baillargeat
Director & CEO of CNRS@CREATE, bridging AI research and industrial deployment.
—Leads the Franco-Singaporean DesCartes program
—Fuses AI and physics into deployable digital twins
Co-founder, investor & board member
Francisco Chinesta
AIRBUS, ESI, RTE, SKF and Keysight chair professor poitions
Director of the DesCartes research programme conducted at CNRS@CREATE (Singapore) on Hybrid Artificial Intelligence for desicison making in critical systems
Get in Touch
Fill out the form below to reach our team for more information or to schedule a consultation regarding our services.